AT-1413 Preis auf Anfrage

Artikelnummer: TGM-T9901A-1600
Artikelname: AT-1413 Preis auf Anfrage
Artikelnummer: TGM-T9901A-1600
Hersteller Artikelnummer: T9901A-1600
Alternativnummer: TGM-T9901A-1600-1MG,TGM-T9901A-1600-5MG
Hersteller: TargetMol
Kategorie: Biochemikalien
AT-1413 is a humanized monoclonal antibody (mAb) targeting CD43. It triggers antibody-dependent cell-mediated cytotoxicity (ADCC) in melanoma cell lines and acute myeloid leukemia (AML) cells. Additionally, AT-1413 shows antitumor activity in an AML mouse model. This compound is applicable for studies involving acute myeloid leukemia, breast cancer, malignant melanoma, and myelodysplastic syndrome. The recommended isotype control is HumanIgG1kappa, Isotype Control.
Target-Kategorie: Others